Search for: "WATSON PHARMACEUTICALS " Results 1 - 20 of 360
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
28 Mar 2011, 9:59 pm by Patent Docs
By Donald Zuhn -- On Friday, in Duramed Pharmaceuticals, Inc. v. [read post]
17 Jun 2009, 3:21 pm
Watson Pharmaceuticals said Wednesday that it would buy the privately held Arrow Group for $1.75 billion in a deal that will help Watson to expand internationally. [read post]
14 Feb 2017, 9:13 pm by Patent Docs
The lawsuit involved Watson's ANDA filing seeking approval for a generic version of Shire's controlled-release oral pharmaceutical composition for the treatment of inflammatory bowel disease, Crohn's disease, and ulcerative colitis, sold by Shire under the brand name LIALDA®. [read post]
20 Mar 2008, 1:55 am
Santa Ana, CA - Watson Laboratories, Inc., through its biotechnology patent attorneys, filed suit in Santa Ana District Court seeking declaratory relief of patent non-infringement and patent invalidity against Barr Pharmaceuticals, Inc. and Duramed Pharmaceuticals, Inc. [read post]
14 Oct 2011, 6:10 pm
Orange County - Noven Pharmaceuticals, Inc. has filed an action for patent infringement against Watson Pharmaceuticals, Inc. in a federal district court in New Jersey. [read post]
25 Apr 2012, 1:39 pm by By MARK SCOTT
Watson Pharmaceuticals agreed on Wednesday to buy the Swiss drug maker Actavis Group for up to 4.5 billion euros ($5.9 billion), as the American company looked to expand its presence in overseas markets. [read post]
24 Apr 2012, 7:33 am by By MARK SCOTT
Watson Pharmaceuticals is expected to offer 4.5 billion euros for the Swiss drug maker Actavis Group, in a deal that would create one of the world's largest generic drug manufacturers. [read post]
19 Oct 2012, 6:13 pm by John W. Arden
For two other drugs, Watson and Actavis would be required to relinquish the marketing rights to another firm.The case is Watson Pharmaceuticals, Inc., FTC Dkt. [read post]
9 Jun 2011, 10:16 am
Indianapolis, IN - Patent lawyers for Alcon Research Ltd of Fort Worth, Texas, Alcon Pharmaceuticals LTD of Switzerland, and Kyowa Haddo Kirin Co. of Japan filed a patent infringement in alleging Watson Laboratories Inc and Watson Pharma, Inc. of Parsippany, New Jersey, and Watson Laboratories, of Corona, California, infringed the following patent prior to the expiration: Patent No. 5,641,805, Topical ophthalmic formulations for treating allergic eye diseases,… [read post]
4 Dec 2007, 9:28 pm
By Sherri Oslick -- Biovail Laboratories International SRL, a subsidiary of Biovail Corporation, and Watson Pharmaceuticals, Inc., have announced that they have reached a settlement agreement in Biovail's lawsuit against Andrx Pharmaceuticals, Inc., a subsidiary of Watson. [read post]
12 Feb 2007, 9:37 pm
  The suit was filed in the Southern District of Florida in December 2005 by Andrx Pharmaceuticals, which was acquired by Watson last year. [read post]
21 Sep 2015, 7:00 am by Steve Brachmann
Just a few months after establishing this health and wellness cloud platform, IBM has secured its first Foundational Life Sciences partner for Watson Health in Teva Pharmaceutical Industries (NYSE:TEVA) of Petah Tikva, Israel. [read post]
8 Nov 2017, 7:26 am by CJ Haddick
Paul Insurance companies owe no duty to defend or indemnify Watson Pharmaceutical in governmental suits against the pharmaceutical company over the deceptive marketing of opioids. [read post]
2 May 2010, 9:52 pm by Patent Docs
• Defendants: Watson Pharmaceuticals Inc.; Watson... [read post]
12 Dec 2011, 5:37 pm
On one side, Watson could identify potential drug targets that could lead to improved research and development for new pharmaceutical drugs. [read post]